Karen Smith
Director/Board Member at EMYRIA LIMITED
Net worth: 219 745 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Martin | M | 52 | 31 years | |
| Robert Foster | M | 65 | 31 years | |
| Peter Greenleaf | M | 54 | 6 years | |
| Michael Winlo | M | - | 5 years | |
| Stephen Robertson | M | 42 | 10 years | |
| Alexander Macrae | M | 61 | 8 years | |
| Daniel Billen | M | 70 | 5 years | |
| Prathyusha Durabaibu | F | 46 | 5 years | |
| Aaron Rosenberg | M | - | 3 years | |
| Simon Read | M | - |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | - |
| Laura Shawver | M | 66 |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Philip Low | M | 76 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | 2 years |
| H. Parker | F | 68 | 10 years | |
| Louise Wilkie | F | - | 4 years | |
| Kimberly McCutcheon Jablonski | F | - | 21 years | |
| Sandy Mong | M | - |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | - |
| Haig Aghajanian | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | 2 years |
| Lexi O’Halloran | F | - | - | |
| Scott Willoughby | M | - | - | |
| June Bray | F | 70 | 2 years | |
| John Markels | M | 58 | 4 years | |
| Margaret Somerville | F | - | - | |
| Stewart A. Low | M | - |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | - |
| Karen Smith | F | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Phillip Ramsey | M | - | - | |
| Brinda Balakrishnan | M | 44 | 3 years | |
| James Meyers | M | 59 | 5 years | |
| Helen Torley | M | 61 | 8 years | |
| Jon Filderman | M | - | 3 years | |
| Duncan Moore | M | 65 | 8 years | |
| R. MacKay-Dunn | M | 73 | 5 years | |
| Kenneth Hillan | M | 63 | 4 years | |
| Robert Carey | M | 65 | 8 years | |
| Jill Leversage | F | 67 | 5 years | |
| Simon Read | M | 53 |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | 3 years |
| Jeffrey Bailey | M | 62 | 1 years | |
| Linda Bain | F | 53 |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | 1 years |
| Daniel Hasler | M | 66 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | - |
| Rita Karachun | F | 63 | 3 years | |
| Greg Hutchinson | M | - | 1 years | |
| David Jaynee | M | 67 | 9 years | |
| Gregory Davis | M | - | 4 years | |
| Tim Power | M | - | 18 years | |
| Jerome Mychalowych | M | - | 3 years | |
| Scott Habig | M | 64 | 2 years | |
| Lisa Wyman | F | - | 5 years | |
| Jamie Bernard | M | - | 4 years | |
| Sue Evans | F | - | 10 years | |
| Matthew Donley | M | 55 | 5 years | |
| Amy Pooler | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert F. Apple | M | 58 | 16 years | |
| Christopher Lowe | M | 56 | 3 years | |
| Jeffrey Edwards | M | 63 | 22 years | |
| Peter J. Graham | M | 57 | 7 years | |
| James Hindman | M | 63 | 31 years | |
| Steven R. Deitcher | M | 59 |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | - |
| James Cornelius | M | 81 | 10 years | |
| Joseph Zakrzewski | M | 60 | 11 years | |
| Peter R. Dolan | M | 68 | 18 years | |
| Leonard S. Jacob | M | 75 | 15 years | |
| Jacques Gonella | M | 82 | 18 years | |
| Ted Monohon | M | 58 | 4 years | |
| John Quisel | M | 52 | 14 years | |
| David Pyott | M | 70 | 17 years | |
| Gary Loeb | M | 54 | 2 years | |
| Habib Dable | M | 54 | 5 years | |
| Caryn McDowell | F | 54 | 2 years | |
| Ambrose Bailey | M | 60 | - | |
| Vivid Sehgal | M | 56 | 8 years | |
| Herb Boyer | M | 87 | 19 years | |
| Kathy Yi | F | 52 | 2 years | |
| Francois Nader | M | 67 | 7 years | |
| Heather Erickson | F | - | 8 years | |
| Sona Saira Ramasastry | F | 48 | 10 years | |
| Michael Holmes | M | - | 17 years | |
| Russell Cox | M | 60 | 6 years | |
| R. Ramelmeier | M | 62 | 5 years | |
| John Tsai | M | 57 | 11 years | |
| Laura Hamill | F | 60 | 1 years | |
| Thomas McCourt | M | 66 | 5 years | |
| Edward Rebar | M | 56 | 22 years | |
| Mark W. Durand | M | 64 | 17 years | |
| Douglas Manion | M | 64 | 11 years | |
| Vicki Sato | M | 75 | 15 years | |
| Harrison Bains | M | 80 | 16 years | |
| Louis J. Freeh | M | 74 | 8 years | |
| Robert Williams | M | 75 | 7 years | |
| Stephen Dilly | M | 64 | 10 years | |
| Heather Turner | F | 51 | 1 years | |
| Richard Pops | M | 62 | 15 years | |
| Roger Jeffs | M | 62 | 2 years | |
| George Golumbeski | M | 67 | 7 years | |
| Jean George | F | 66 | 15 years | |
| Tram Bui | F | - | 2 years | |
| Steven Mento | M | 72 | 14 years | |
| Gerald Bruce | M | 68 | 8 years | |
| David J. Helfgott | M | - | - | |
| Kemal Malik | M | 61 | - | |
| Rahul Khara | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 81 | 81.82% |
| Canada | 13 | 13.13% |
| Australia | 4 | 4.04% |
| Denmark | 1 | 1.01% |
| Ireland | 1 | 1.01% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karen Smith
- Personal Network
